Inhalation Anesthesia

Inhalation Anesthesia Market Value to Cross US$ 24 Bn by 2030 Inhalation Anesthesia Market (By Product Type: Apparatus (Isoflurane, Sevoflurane, Desflurane, and Others), Anesthetics, Accessories; By Deployment: Human Healthcare, Veterinary Healthcare; By Organization Size: Hospitals, Clinics, Ambulatory Surgical Centres, Others) - Global Industry Analysis, Size, Share, Growth, Trends Analysis, Regional Outlook and Forecasts, 2021 - 2030

Share This Article

The inhalation anesthesia market is expected to exhibit a CAGR of 5.5% from 2021 to 2030 and is projected to reach US$ 24 Billion by 2030, according to a 2021 study by Precedence Research, the Canada based market insight company.

The report contains 150+ pages with detailed analysis. The study provides the overall revenue of the global inhalation anesthesia market from 2017 to 2030, considering 2020 as the base year and 2030 as the forecast year.

The global inhalation anesthesia market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the inhalation anesthesia industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1247

Growth Factors:

Growing numbers of surgical procedures across the globe, along with emergence of the trauma cases worldwide are some among the major factors driving growth of the global market. Additionally, increasing geriatric population, increasing cancer patient pool, rising cardiovascular, gastrointestinal, respiratory, neurological disorders are expected to propel growth of the target market in next 10 years.The North American region is expected to dominate in the global inhalation anesthesia market over the forecast period. The growth is attributed to increasing chronic diseases and availability for advanced healthcare facility in the U.S. Additionally, increasing number of surgical procedures along with early acceptance of advanced technology in the region are expected to fuel growth of the target market over the forecast period. However, factors such as side effects of inhalation anesthetics as well as lack of awareness may restrict the inhalation anesthesia market globally. Nevertheless, untapped markets can create lucrative growth opportunity for the key players in the global market. Key players are using innovative technology to deliver high-quality goods that meet the changing needs of the end-user industries which is anticipated to propel growth of the global market in the near future.

Report Coverage: 

Report Highlights Details
Market Size USD 24 Billion by 2030
Growth Rate CAGR of 5.5% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segmentes Covered Product, Application, End use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Piramal Critical Care, Baxter, Midmark Corporation, Halocarbon, Hengrui Medicine, Kent Scientific Corporation, Merck KGaA, BOC, AbbVie Inc. Raman & Weil Pvt. Ltd.

Report Highlights:

  • On the basis of anesthetics, product type segment will register supreme share in the near future. The anesthetics segment accounted for the maximum share of around 42% in year 2020 in terms of revenue. Apparatus segment will be increasing at substantial pace and will fuel growth of the inhalation anesthesia industry in the near future.
  • Based on application the global market is categorized as human healthcare and veterinary healthcare among which the services segment will register maximum share in the near future. Human healthcare segment is anticipated to register highest growth rate as well as market share over the forecast period of time.
  • Among the end user hospitals estimated as a dominant segment, along with maximum share in year 2020. The growth is attributed to growing adoption in the hospitals across the globe. Along with this the clinics segment is anticipated to grow at the noteworthy growth rate and will augment the market revenue.
  • Kent Scientific Corporation accounted for a significant share of the global inhalation anesthesia market due to the implementations of its innovative business strategies. Key strategies applied by the company will offers tremendous growth prospects for the vendors worldwide.

Regional Analysis:

The report study offers global industry projections of inhalation anesthesia products round various regions like Asia-Pacific, Latin America, Europe, North America, and Middle East and Africa. The North Americawill lead the worldwide industry owing togrowing prevalence of numerous chronic diseases, presence of advanced healthcare facilities, coupled with presence of major companies in the North American countries. The Asia Pacific market is probable to list the striking CAGR, on account of growing demand for the inhalation anesthesiain emerging economies. Likewise, utmost of the companies functioning in the market are advancing deeply in order to get the modest advantage in the inhalation anesthesia market in the Asia Pacific. The market in the Europe is expected to hold significant market share and the growth is attributed to the increased prevalence of respiratory diseases in the France, Russia, and U.K. of the region. The Latin America inhalation anesthesia industry is anticipated to grow at reasonable CAGR in the forecast period of time. Likewise, Middle East and Africa region is projected to create worthwhile growth opportunities in the target industry.

Top Players Contending in the Market:

The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global inhalation anesthesia market are as follows:

  • Piramal Critical Care
  • Baxter
  • Midmark Corporation
  • Halocarbon
  • Hengrui Medicine
  • Kent Scientific Corporation
  • Merck KGaA
  • BOC
  • AbbVie Inc.
  • Raman & Weil Pvt. Ltd.

Market Segmentation

By Product Type

  • Apparatus
    • Isoflurane
    • Sevoflurane
    • Desflurane
    • Others
  • Anesthetics
  • Accessories

By Application

  • Human Healthcare
  • Veterinary Healthcare

By End user

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Others

Regional Segmentation

  • North America (U.S. and Canada)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Some of the key highlights covered in the report include:

Market Demand-Supply Analysis – The report covers detailed insights into demand and supply forces prevailing in the global inhalation anesthesia market. It examines trends and factors influencing demand for inhalation anesthesia globally and gauges the impact of the same on the production.

Pricing Analysis – The report presents an exclusive pricing analysis. It compares pricing strategies adopted by the leading market players and identifies the most remunerative strategies.

Market Segmentation – The report segments the global market in terms of diverse criteria. It identifies the leading segment within each category and identifies growth drivers and restraints affecting growth across each segment.

Regional Analysis – The report segments the market in terms of North America, Europe, Latin America, Asia Pacific, and Rest of the World in terms of region. It has chapters exclusively dedicated to analyzing growth trends across each region. It identifies growth drivers as well challenges affecting demand for inhalation anesthesia across the world.

Competitive Analysis – Some of the leading market players are profiled in the report on inhalation anesthesia. The report offers an estimation of share individually help by the market players and determines the impact of some of their popular strategies.

COVID-19 Impact Analysis – This chapter is exclusively dedicated to gauging how the market has evolved or will develop in the post-pandemic era.

Growth Recommendations – In the end, the report presents valuable recommendations to ready businesses for unforeseen challenges in the near future.

Why should you invest in this report?

If you are aiming to enter the global inhalation anesthesia market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for inhalation anesthesia are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Inhalation Anesthesia Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Inhalation Anesthesia Market

5.1. Covid-19: Inhalation Anesthesia Industry Impact
5.2. Inhalation Anesthesia Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Inhalation Anesthesia Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Inhalation Anesthesia Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Inhalation Anesthesia Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Surge in the prevalence of disorders such as respiratory diseases, gastrointestinal disorders, and cancer across the globe.
6.1.1.2. Increasing number of surgical procedures worldwide.
6.1.1.3. Growing geriatric population and growing number of emergency cases and accidents.
6.1.2. Market Restraints
6.1.2.1. Side effects associated with the inhalation anesthetics is major factor hampering target market growth
6.1.3. Market Opportunities
6.1.3.1. Emerging markets and ongoing research & development in the healthcare sector technologies

Chapter 7. Global Inhalation Anesthesia Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Inhalation Anesthesia Market Revenue by Market Players (2017 – 2020)
7.1.1.2. Inhalation Anesthesia Market Revenue Market Share by Market Players (2017 – 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Process Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Inhalation Anesthesia Market, By Product Type

8.1. Inhalation Anesthesia Market, 2017-2030
8.2. Apparatus
8.2.1.1. Market Revenue Forecast (2017-2030)
8.3. Anesthetics
8.3.1.1. Market Revenue Forecast (2017-2030)
8.4. Accessories
8.4.1.1. Market Revenue Forecast (2017-2030)

Chapter 9. Global Inhalation Anesthesia Market, By Application

9.1. Inhalation Anesthesia Market, 2017-2030
9.2. Human Healthcare
9.2.1.1. Market Revenue Forecast (2017-2030)
9.3. Veterinary Healthcare
9.3.1.1. Market Revenue Forecast (2017-2030)

Chapter 10. Global Inhalation Anesthesia Market, By End User

10.1. Inhalation Anesthesia Market, 2017-2030
10.2. Hospitals
10.2.1.1. Market Revenue Forecast (2017-2030)
10.3. Clinics
10.3.1.1. Market Revenue Forecast (2017-2030)
10.4. Ambulatory Surgical Centers
10.4.1.1. Market Revenue Forecast (2017-2030)
10.5. Others
10.5.1.1. Market Revenue Forecast (2017-2030)

Chapter 11. Global Inhalation Anesthesia Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product Type(2017-2030)
11.1.2. Market Revenue Forecast by End-user(2017-2030)
11.1.3. Market Revenue Forecast by Organization Size(2017-2030)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2017-2030)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2017-2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Product Type (2017-2030)
11.2.2. Market Revenue Forecast by End-user (2017-2030)
11.2.3. Market Revenue Forecast by Organization Size (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2017-2030)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2017-2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product Type (2017-2030)
11.3.2. Market Revenue Forecast by End-user (2017-2030)
11.3.3. Market Revenue Forecast by Organization Size (2017-2030)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2017-2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product Type (2017-2030)
11.4.2. Market Revenue Forecast by End-user (2017-2030)
11.4.3. Market Revenue Forecast by Organization Size (2017-2030)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2017-2030)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2017-2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product Type (2017-2030)
11.5.2. Market Revenue Forecast by End-user (2017-2030)
11.5.3. Market Revenue Forecast by Organization Size (2017-2030)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2017-2030)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2017-2030)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2017-2030)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2017-2030)

Chapter 12. Company Profiles

12.1. AbbVie Inc.
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Product Type
12.1.3. Revenue, Price, and Gross Margin (2017-2020)
12.1.4. Recent Developments and Strategies
12.2. Baxter
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Product Type
12.2.3. Revenue, Price, and Gross Margin (2017-2020)
12.2.4. Recent Developments and Strategies
12.3. BOC
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Product Type
12.3.3. Revenue, Price, and Gross Margin (2017-2020)
12.3.4. Recent Developments and Strategies
12.4. Halocarbon
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Product Type
12.4.3. Revenue, Price, and Gross Margin (2017-2020)
12.4.4. Recent Developments and Strategies
12.5. Hengrui Medicine
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Product Type
12.5.3. Revenue, Price, and Gross Margin (2017-2020)
12.5.4. Recent Developments and Strategies
12.6. Kent Scientific Corporation
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Product Type
12.6.3. Revenue, Price, and Gross Margin (2017-2020)
12.6.4. Recent Developments and Strategies
12.7. Merck KGaA
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Product Type
12.7.3. Revenue, Price, and Gross Margin (2017-2020)
12.7.4. Recent Developments and Strategies
12.8. Midmark Corporation
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Product Type
12.8.3. Revenue, Price, and Gross Margin (2017-2020)
12.8.4. Recent Developments and Strategies
12.9. Piramal Critical Care
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Product Type
12.9.3. Revenue, Price, and Gross Margin (2017-2020)
12.9.4. Recent Developments and Strategies
12.10. Raman & Weil Pvt. Ltd.
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Product Type
12.10.3. Revenue, Price, and Gross Margin (2017-2020)
12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1247

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →